| Literature DB >> 18784245 |
Daniel Manzoni de Almeida1, Matheus de F Fernandes-Pedrosa, Rute M Gonçalves de Andrade, José Roberto Marcelino, Hisako Gondo-Higashi, Inácio de L M Junqueira de Azevedo, Paulo Lee Ho, Carmen van den Berg, Denise V Tambourgi.
Abstract
Envenomation by Loxosceles species (brown spider) can lead to local dermonecrosis and to serious systemic effects. The main toxic component in the venom of these spiders is sphingomyelinase D (SMase D) and various isoforms of this toxin are present in Loxosceles venoms. We have produced a new anti-loxoscelic serum by immunizing horses with recombinant SMase D. In the present study, we compared the neutralization efficacy of the new anti-loxoscelic serum and anti-arachnidic serum (the latter serum is used for therapy for loxoscelism in Brazil) against the toxic effects of venoms from spiders of the genus Loxosceles. Neutralization tests showed that anti-SMase D serum has a higher activity against toxic effects of L. intermedia and L. laeta venoms and similar or slightly weaker activity against toxic effects of L. gaucho than that of Arachnidic serum. These results demonstrate that recombinant SMase D can replace venom for anti-venom production and therapy.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18784245
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345